Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 651,640 | reported | 02 Mar 2026 | tx 18+2,273,590−123,086 |
| Galecto, Inc. | 37,313 | reported | 23 Mar 2026 | tx 1+37,313 |
| BridgeBio Pharma, Inc. | 21,131 | reported | 28 Dec 2020 | tx 61+220,765−176,437 |
| Oruka Therapeutics, Inc. | 17,500 | reported | 02 Jun 2025 | tx 1+17,500 |
| Eidos Therapeutics, Inc. | 0 | reported | 26 Jan 2021 | tx 59+69,520−305,823 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | GRANT_AWARD | Galecto, Inc. | 37,313 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | Spyre Therapeutics, Inc. | 9,100 | 42.49 USD | |
| 02 Mar 2026 | SALE | Spyre Therapeutics, Inc. | 5,900 | 41.73 USD | |
| 02 Feb 2026 | SALE | Spyre Therapeutics, Inc. | 957 | 31.82 USD | |
| 02 Feb 2026 | SALE | Spyre Therapeutics, Inc. | 14,043 | 32.87 USD | |
| 09 Jan 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 528,000 | 0.00 USD | deriv |
| 02 Jan 2026 | SALE | Spyre Therapeutics, Inc. | 12,709 | 30.47 USD | |
| 02 Jan 2026 | SALE | Spyre Therapeutics, Inc. | 100 | 32.39 USD | anomaly |
| 02 Jan 2026 | SALE | Spyre Therapeutics, Inc. | 2,191 | 31.79 USD | |
| 01 Dec 2025 | SALE | Spyre Therapeutics, Inc. | 4,005 | 29.83 USD | |
| 01 Dec 2025 | SALE | Spyre Therapeutics, Inc. | 10,995 | 28.73 USD | |
| 03 Nov 2025 | SALE | Spyre Therapeutics, Inc. | 28,155 | 23.13 USD | |
| 03 Nov 2025 | SALE | Spyre Therapeutics, Inc. | 16,845 | 23.66 USD | |
| 02 Jun 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 15 Jan 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 370,000 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Spyre Therapeutics, Inc. | 400 | 9.82 USD | |
| 01 Feb 2024 | GRANT_AWARD | Spyre Therapeutics, Inc. | 277,750 | 0.00 USD | deriv |
| 24 Nov 2023 | CONVERSION | Spyre Therapeutics, Inc. | 723,440 | 0.00 USD | |
| 24 Nov 2023 | CONVERSION | Spyre Therapeutics, Inc. | 18,086 | 0.00 USD | deriv |
| 22 Nov 2023 | GRANT_AWARD | Spyre Therapeutics, Inc. | 374,000 | 0.00 USD | deriv |
| 26 Jan 2021 | TENDER | Eidos Therapeutics, Inc. | 50,699 | — | |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 9,469 | — | deriv |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 53,157 | — | deriv |
| 28 Dec 2020 | SALE | BridgeBio Pharma, Inc. | 8,563 | 69.94 USD | |
| 28 Dec 2020 | SALE | BridgeBio Pharma, Inc. | 10,937 | 69.34 USD |